Bender Robert & Associates
JNJ icon

Bender Robert & Associates’s Johnson & Johnson JNJ Stock Holding History

Bender Robert & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,578
Closed -$523K – 61
2024
Q2 		$523K Buy
+3,578
New +$532K 0.11% 34

Other funds holding JNJ

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bender Robert & Associates's JNJ Position: Q3 2026 in Review

Bender Robert & Associates reduced its Johnson & Johnson (JNJ) stake by 0.53% in Q3 2026, selling an estimated $4.48K and leaving 3,207 shares worth $849K. The position accounts for 0.16% of the portfolio, ranked #30.

Bender Robert & Associates first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $971K in Q4 2022. 3,821 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Bender Robert & Associates held 3,207 shares of Johnson & Johnson worth $849K as of Q3 2026.
  • Bender Robert & Associates sold 17 Johnson & Johnson shares in Q3 2026, an estimated $4.48K.
  • Johnson & Johnson made up 0.16% of Bender Robert & Associates's portfolio in Q3 2026, its #30 holding.
  • Bender Robert & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Bender Robert & Associates's Johnson & Johnson position peaked at $971K in Q4 2022.
  • 3,821 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Bender Robert & Associates's 13F filing for Q3 2026, filed 21 Oct 2026.